The announcement of SLC Board of Directors'
Resolution to convene the 2022 Annual General Meeting
(Additional election matters)
Date of events
2022/03/16
To which item it meets
paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/16
2.General shareholders' meeting date:2022/06/01
3.General shareholders' meeting location:
No.6, Yule St., Toufen City, Miaoli County 351, Taiwan
(GRAND ROYAL HOTEL)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)2021 Business Report
(2)Audit Committee's Review Report
(3)2021 distributable compensation for employees and directors
(4)Report on the implementation of the Operation Enhancement Plan
6.Cause for convening the meeting II.Acknowledged matters:
(1)The 2021 Business Report and Financial Statements
(2)The Company's 2021 earnings distribution
7.Cause for convening the meeting III.Matters for Discussion:
(1)Amendment to the Company's "Articles of Association"
(2)Amendment to the Company's "Acquisition or Disposal of Assets Handling
Procedures"
8.Cause for convening the meeting IV.Election matters:
By-election of an independent director.
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/04/03
12.Book closure ending date:2022/06/01
13.Any other matters that need to be specified:
(1)According to Articles 172-1 and 192-1 of the Company Law, shareholders
who hold 1% or more of the company's total issued shares may submit a
written proposal and a list of candidates for independent directors.
(2)During this acceptance period, from March 25, 2022 to April 6, 2022,
every day from 9:00 am to 5:00 pm; Accepting place: the company's
accounting department, address: Branch, Zhunan Town, Miaoli County
29 Middle Road.
(3)The company's second domestic secured conversion of corporate bonds
is suspended from April 3, 2022 to June 1, 2022.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Savior Lifetec Corporation published this content on 16 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2022 09:57:07 UTC.
SAVIOR LIFETEC CORPORATION is a Taiwan-based company principally engaged in the development, manufacture and distribution of antibiotic bulk pharmaceutical chemicals and intermediates. The Companyâs products portfolio mainly consists of Meropenem and Imipenem/Cilastatin, Meropenem as well as Ertapenem, among others, which are used as spectrum antibiotics. In addition, it is involved in the provision of APIs intermediates as well as bio-pharmaceutical technology services. The Company distributes its products to Europe, the Americas, Asia and other markets.
SAVIOR LIFETEC CORPORATION 
